BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18058001)

  • 1. Safe and effective permeation enhancers for oral drug delivery.
    Whitehead K; Karr N; Mitragotri S
    Pharm Res; 2008 Aug; 25(8):1782-8. PubMed ID: 18058001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of synergistic permeation enhancers for oral drug delivery.
    Whitehead K; Karr N; Mitragotri S
    J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic analysis of chemical permeation enhancers for oral drug delivery.
    Whitehead K; Mitragotri S
    Pharm Res; 2008 Jun; 25(6):1412-9. PubMed ID: 18311478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
    Fein KC; Gleeson JP; Newby AN; Whitehead KA
    Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico modelling of permeation enhancement potency in Caco-2 monolayers based on molecular descriptors and random forest.
    Welling SH; Clemmensen LK; Buckley ST; Hovgaard L; Brockhoff PB; Refsgaard HH
    Eur J Pharm Biopharm; 2015 Aug; 94():152-9. PubMed ID: 26004819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
    Lamson NG; Cusimano G; Suri K; Zhang A; Whitehead KA
    Mol Pharm; 2016 Feb; 13(2):578-85. PubMed ID: 26730955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.
    Fein KC; Lamson NG; Whitehead KA
    Pharm Res; 2017 Jun; 34(6):1320-1329. PubMed ID: 28374339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
    Gupta V; Hwang BH; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
    Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
    Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
    Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
    Stuettgen V; Brayden DJ
    AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
    Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
    Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
    Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin.
    Shah RB; Palamakula A; Khan MA
    J Pharm Sci; 2004 Apr; 93(4):1070-82. PubMed ID: 14999743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
    Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
    Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
    J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.